Availability to antibiotics of particular importance

In a pilot project, the Public Health Agency of Sweden has investigated whether a model with guaranteed reimbursement to the pharmaceutical company can improve access to particularly important antibiotics in Sweden. An initial evaluation shows that the studied reimbursement model led to increased access to the antibiotic products in our country, earlier than in other comparable European countries.

Publication in Swedish: Tillgänglighet till särskilt viktiga antibiotika

Related reading

Availability of antibiotics